Defining Target Engagement Required for Efficacy

Autor:	Charles W, Lugar, Christian A, Clarke, Richard, Morphy, Helene, Rudyk, Selma, Sapmaz, Ryan E, Stites, Grant M, Vaught, Kelly, Furness, Howard B, Broughton, Greg L, Durst, David K, Clawson, Stephanie L, Stout, Sherry Y, Guo, Jim D, Durbin, Keith R, Stayrook, Denise D, Edmondson, Kristy, Kikly, Nicole E, New, Holly A, Bina, Mark G, Chambers, Pamela, Shetler, William Y, Chang, Veavi Ching-Yun, Chang, Rob, Barr, Wendy H, Gough, Jimmy P, Steele, Brian, Getman, Nita, Patel, Brian M, Mathes, Timothy I, Richardson
Rok vydání:	2021
Předmět:	Binding Sites Arthritis Interleukin-17 Thiophenes Molecular Dynamics Simulation Nuclear Receptor Subfamily 1 Group F Member 3 Crystallography X-Ray Ligands Disease Models Animal Mice Structure-Activity Relationship Drug Design Leukocytes Mononuclear Animals Humans Female Half-Life Protein Binding
Zdroj:	Journal of medicinal chemistry. 64(9)
ISSN:	1520-4804
Popis:	The Th17 pathway has been implicated in autoimmune diseases. The retinoic acid receptor-related orphan receptor C2 (RORγt) is a master regulator of Th17 cells and controls the expression of IL-17A. RORγt is expressed primarily in IL-17A-producing lymphoid cells. Here we describe a virtual screen of the ligand-binding pocket and subsequent screen in a binding assay that identified the 1-benzyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ef03d39fb502b855beadc34c7a19e1e7 https://pubmed.ncbi.nlm.nih.gov/33852312 Zobrazit plný text záznamu